Low dose venetoclax as a single agent treatment of plasma cell malignancies harboring t(11;14).
Nahi H, Kashif M, Klimkowska M, Karvouni M, Wallblom A, Gran C, Hauenstein J, Frengen N, Gustafsson C, Afram G, Uttervall K, Lund J, Månsson R, Wagner AK, Alici E.
Nahi H, et al. Among authors: kashif m.
Am J Hematol. 2021 Aug 1;96(8):925-933. doi: 10.1002/ajh.26207. Epub 2021 May 18.
Am J Hematol. 2021.
PMID: 33901326
Free article.